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Abstract
Genetic and biochemical analyses of human papillomavirus type 16 (HPV16) capsids have shown that certain conserved L1
cysteine residues are critical for capsid assembly, integrity, and maturation. Since previous studies utilized HPV capsids
produced in monolayer culture-based protein expression systems, the ascribed roles for these cysteine residues were not
placed in the temporal context of the natural host environment for HPV, stratifying and differentiating human tissue. Here
we extend upon previous observation, that HPV16 capsids mature and become stabilized over time (10-day to 20-day) in a
naturally occurring tissue-spanning redox gradient, by identifying temporal roles for individual L1 cysteine residues.
Specifically, the C175S substitution severely undermined wild-type titers of the virus within both 10 and 20-day tissue, while
C428S, C185S, and C175,185S substitutions severely undermined wild-type titers only within 20-day tissue. All mutations led
to 20-day virions that were less stable than wild-type and failed to form L1 multimers via nonreducing SDS-PAGE.
Furthermore, Optiprep-fractionated 20-day C428S, C175S, and C175,185S capsids appeared permeable to endonucleases in
comparison to wild-type and C185S capsids. Exposure to an oxidizing environment failed to enhance infectious titers of any
of the cysteine mutants over time as with wild-type. Introduction of these cys mutants results in failure of the virus to
mature.
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Introduction
Human papillomaviruses (HPVs) contain a single, circular
dsDNA genome of approximately 8 kb which associates with
cellular histonesto form a minichromosome. Thisminichromosome
is encapsidated within a nonenveloped, icosahedral capsid com-
posed of the late proteins, L1 and L2. Similar to polyomaviruses,
360 monomers of the major capsid protein L1 assemble into 72
pentameric capsomeres which are geometrically arranged on a
T=7 icosahedral lattice [1,2,3,4,5]. Recent cryo-electron micros-
copy image reconstructions of HPV16 pseudovirions (PsV) support
previous biochemical analyses suggesting that capsids can be
maximally occupied with 72 L2 proteins per virion [6,7].
Due to the relative inefficiency of organotypic culture in the
production of native HPVs, structural analyses of HPV capsids has
been largely limited to the utilization of more efficient monolayer
culture-derived papillomavirus particles such as virus-like particles
(VLPs), and PsV [6,7,8,9,10,11,12,13,14,15,16,17,18,19,20]. X-
ray crystallographic data has been obtained from an HPV16 L1
with N-terminal and C-terminal deletions forming a 12-pentamer,
small VLP [13]. However, the small size of this structure and lack
of disulfide bonds leave many of the structural details of native
HPV16 open for interpretation [13,14,15,16,17,18,19,20]. Re-
cently, a high-resolution cryo-electron microscopy image recon-
struction of native bovine papillomavirus particles (BPV) depicted
two separate disulfide bonds. The C171-C426 disulfide bond
forms an interpentameric interaction between two highly con-
served cysteine residues homologous to C175 and C428 in
HPV16. The BPV C22–C473 disulfide bond forms an intrapen-
tameric interaction between two less conserved cysteine residues
that are only conserved among papillomaviruses from ruminants
[21]. Supporting the presence of a C171–C426 disulfide bond in
other HPV types, mass spectrometry analysis of L1 dimers from
non-reduced HPV18 VLPs depicted the presence of a C175–C429
disulfide bond [14]. Genetic and biochemical analyses of HPV16
and HPV33 VLPs and PsV have also shown the importance of
these conserved cysteines in the structural integrity of particles
[6,14,16,18,20]. Previous studies have also highlighted the
potential structural role of C185, which neighbors C175 on the
EF loop of HPV16 L1. C185 has been shown to affect the
structural integrity of HPV16 VLPs and has been theorized to play
a role in the production of aberrant L1 dimers [6,16].
Since previous studies into the disulfide bonding patterns of
HPV16 capsids utilized particles produced in monolayer culture,
or from fully developed BPV-containing warts, disulfide interac-
tions were not placed in the temporal context of stratified and
differentiating human tissue. Here we extend upon our previous
observation, that HPV16 capsids become stabilized over time
[22,23,24]. Our previous studies showed that HPV16 formed
infectious but unstable, poorly antibody-mediated neutralizable
particles after 10 days of growth in host tissue, requiring another
ten days of growth to form stable, antibody-mediated neutralizable
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identified temporal roles for individual C175, C185, and C428
L1 cysteine residues. Only the C175S substitution severely
undermined wild-type levels of infectious virus within both 10-
(reducing environment) and 20-day (oxidative environment) tissue,
while C428S, C185S, and C175,185S substitutions all undermined
wild-type levels of infectious virus only within 20-day tissue
suggesting they are important to stabilize the particles over time.
Interestingly, upon fractionation more noninfectious defective
virus appeared to co-migrate with infectious 20-day C428S,
C175S, and C175,185S virions in comparison to wild-type and
C185S virions, suggesting that the mutations permeabilized the
capsid lumen to treatment with an endonuclease. In addition,
treatment of raft cultures with oxidized glutathione (GSSG) failed
to enhance infectious titers within any mutant tissues compared to
wild-type, suggesting that these residues are important in the
redox-dependent enhancement observed of wild-type HPV16
infectivity in a more oxidative environment. Together these results
allowed us to hypothesize that a complex, temporal interplay of
disulfide bond formation, disruption, and reformation occurs
between C175, C185, and C428. These data support previous
reports utilizing VLPs or PsVs that an initial C185–C428 disulfide
bond may form in order to prime formation of a C175–C428
disulfide bond during capsid assembly in stratifying and differen-
tiating human epithelial tissue [6,16].
Results
Establishment of stable cell lines maintaining episomal
HPV16 DNA
To develop producer cell lines which can synthesize organotypic
culture-derived native virions from differentiating epithelia,
primary human foreskin keratinocytes (HFKs) were electroporated
with linearized wild-type and site-directed mutagenized
HPV16(114/B) DNA [9]. The recircularization and maintenance
of episomal HPV16 viral genomes for representative HPV16 L1
C428S, C175S, C185S, and C175,185S cell lines can be seen in
Figure 1. Data for wild-type and C428S HPV16-containing cell
lines have been published previously [22,25]. The total number of
episomal copies per cell was less in mutant cell lines (,50–200
copies/cell) than the wild-type cell line utilized (.1,000 copies/
cell). Importantly, the lower copy numbers observed in monolayer
culture in the mutant cell lines are not significant regarding
productivity of tissues since previous reports have suggested that
copy number does not directly correlate with the titer of HPV-
infected organotypic tissues [25,26,27]. Quantifying genome
equivalents and the detection of the major capsid protein via
Western blot allowed for the analysis of the relative infectivity of
viral stocks produced by HPV-infected organotypic tissues. For
each mutant genome, multiple episomal DNA-containing cell lines
were produced and utilized in experiments. In addition, L1 ORFs
were sequenced to verify the existence of the intended mutation,
and the absence of erroneous mutations. Only then were stable cell
lines allowed to grow as stratified and differentiated epithelial
tissues in organotypic culture (Fig. 2). Importantly, mutant-
infected tissues did not show a significantly different phenotype
than wild-type-infected tissues (Fig. 2) and total L1 protein
concentration was similar in wild-type compared to mutant in
10-day tissues (Fig. 3A and 4C).
L1 multimer formation in 10- and 20-day wild-type and
mutant virions
Previous literature suggests that HPV16 and BPV1 PsV can
mature within 293TT cell lysates if incubated overnight at 37uC
[6]. This maturation event is characterized by the formation of
higher-ordered L1 multimers, presumably formed through inter-
pentameric disulfide bonds [6]. Similarly, we have previously
shown that native HPV16 virions are stabilized by a tissue-
spanning redox gradient within human epithelial tissue. Here we
hypothesized that this stabilization event was mediated by the
Figure 1. Episomal maintenance of wild-type and mutant viral
genomes. Southern blot hybridization of a representative HPV16(114/
B)-infected HFK cell lines containing wild-type (WT), and C428S, C175S,
C185S, and C175,185S mutant genomes. Uncut (U) and single BamHI
cut (B) episomal genomes are shown in addition to 1, 10, and 100 viral
genome copies per 5 mg of total genomic DNA.
doi:10.1371/journal.pone.0022427.g001
Figure 2. Stratification of wild-type and mutant organotypic
cultures. Hematoxylin and eosin staining of paraffin-embedded,
10-day wild-type (WT), C428S, C175S, C185S, and C175,185S-infected
organotypic tissue.
doi:10.1371/journal.pone.0022427.g002
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predicted to form a critical interpentameric disulfide bond in
numerous biochemical and genetic analyses [6,14,16,18,21]. To
test this hypothesis, nonreducing Western blot analyses of 10- and
20-day wild-type and mutant viral preparations were performed
(Fig. 4A–C). Consistent with our hypothesis that 10-day virions
lack a stabilizing interpentameric disulfide bond, only monomeric
L1 was observed in both 10-day wild-type and mutant viruses
(Fig. 4A–B). Consistent with our hypothesis that C175 and C428
are involved in stabilizing the particles over time, under
nonreducing conditions L1 multimer formation was only observed
in wild-type 20-day virus (Fig. 4A). Since a significant increase in
L1 protein concentration was observed in wild-type and mutant
20-day tissues compared to 10-day tissues, nonreducing Western
blots were overexposed to determine if multimers were detected in
10-day virus. No multimers were observed in wild-type or mutant
10-day virus in overexposed nonreducing Western blots (data not
shown). L1 multimer formation in wild-type 20-day virus was
always accompanied by an equivalent loss in the monomeric
population (Fig. 4A–C). The lack of L1 multimer formation in all
20-day mutant viruses supports a role for, not only C175 and
C428 in a stabilizing interpentameric disulfide bond, but also for
C185. The total amount of L1 protein in the various tissues that
was able to run on an SDS-PAGE gel is shown in figure 4C. Intact
wild-type virions likely fail to enter the gel as easily as collapsed
C428S virions resulting in more L1 protein signal. In our
experience native virions are not completely reduced to monomers
in the presence of 2-ME and SDS.
DNA encapsidation efficiency of wild-type and mutant
virions
Previous studies indicate that C428S, C175S, and C185S
substitutions in HPV16 VLPs and PsV dramatically alters either
initial assembly of viral particles, or their stabilities after
purification [6,16]. To quantitatively assess capsid stability, the
efficacy of wild-type versus mutant L1 proteins to assemble and
protect viral genomes in the context of stratified and differentiated
epithelial tissues was determined. This was performed by growing
rafts for 10 and 20 days. Viral stocks were either treated with
benzonase in order to eliminate exogenous viral genomes present
within the lysate leaving only endonuclease-resistant or encapsi-
dated genomes, or left untreated so that total viral genomes
present could be quantified [22,23]. Benzonase treatment has been
previously reported to eliminate both chromatin-associated and
chromatin-non-associated DNA, in addition to a large population
of endonuclease-susceptible viral genomes, while leaving the
population of protected viral genomes for downstream analysis
[22,23]. Analysis of non-benzonase-treated viral stocks for total
Figure 3. Expression of L1 in wild-type and mutant 10 day
tissues. Western blot analyses of equal volumes from WT, C428, C175,
C185S, and C175,185S 10-day virus preparations. A representative
Western blot is shown below while a graph depicting the relative L1
protein expression per viral preparation via densitometry is shown
above. The results are means and standard deviations from three
independent experiments.
doi:10.1371/journal.pone.0022427.g003
Figure 4. Nonreducing Western blot analyses of 10 and 20-day wild-type and mutant viruses. Representative Western blot images of
equal volumes of 10 and 20-day wild-type and mutant viruses run under nonreducing (A–B) and reducing (C) conditions. Monomeric L1 (lower band
in A) under nonreducing conditions is shown overexposed in (B). Monoclonal H16.J4 was used to detect HPV16 L1. Multimeric L1 species are
indicated by a box. An arrow points to a faster migrating L1 species which has been previously shown to be present in greater concentration within
purified virions [23].
doi:10.1371/journal.pone.0022427.g004
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mutant samples (data not shown). While total viral genomes
remained statistically similar in these viral stocks, mutations in the
viral genome and host keratinocyte genetic background could alter
translation efficiencies of L1 transcripts. Because of this, total L1
protein within 10-day tissues was estimated by Western blot
analysis (Fig. 3). While a slight increase in total L1 protein levels
was observed in 10-day C175,185S virus compared to wild-type,
no statistical difference was observed for 10-day C428S, C175S, or
C185S viruses. These results suggested that mutations and/or
donor tissues had no major effect on L1 protein expression levels.
HPV titers are measured similar to other viruses such as the
Kaposi’s sarcoma virus (KSHV), quantifying viral genome
equivalents [28,29,30,31,32]. In Fig. 5A, the relative amounts of
HPV titers in 10-day viral preparations are shown. Ten-day
C428S, C175S, C185S, and C175,185S mutants had titers that
were 54%614, 20%615, 110%630, and 145%651, respectively,
of wild-type titers (Table 1). This suggests that C428 was mildly
and C175 was largely important for early viral genome
encapsidation. The observation that 10-day C428S viruses had
titers that were 54% of 10-day wild-type virus was surprising since
the C428S mutation previously led to complete capsid disassembly
when integrated into HPV16 and HPV33 VLPs, and HPV16 PsV
[6,16,18]. We theorize that proper covalent bonding prevents
exposure of viral genomes to benzonase.
Fig. 5B shows the titers measured from 20-day viral prepara-
tions. Compared to 20-day wild-type titers, 20-day C428S, C175S,
C185S, and C175,185S virus preparations contained titers of
8%64, 1%60.05, 13%64, and 14%66, respectively. In addition,
side-by-side analysis of 10-day and 20-day tissues (Fig. 5A–B)
shows that from 10 to 20 days, the titers increased in wild-type-
infected tissues, while the titers dropped in all mutant-infected
tissues (Fig. 5C). This dramatic decrease in titers occurred while
total L1 protein concentration in 20-day virus preparations
appeared equal or higher in mutant preparations compared to
wild-type virus preparations (Fig. 4C). Such dramatic decreases in
titers apparent in 20-day virus preparations compared to 20-day
wild-type virus preparations supports that, over time, C428S,
C175S, and C185S facilitate necessary steps in virion maturation.
This suggests that in the oxidative environment of tissue, disulfide
bonds are necessary to maintain a stable particle.
Infectivity of wild-type and mutant virions
While significant reductions in titers were detected in 10 and 20-
day mutant virus preparations, all preparations contained
quantifiable titers (Fig. 5A–C). These results demonstrated that,
while inefficient, all of the cys mutant L1 proteins tested can
encapsidate and protect viral genomes from endonucleases. To
determine infectivity of the mutant particles, a previously reported
RT-qPCR-based infectivity assay measuring the abundance of
E1‘E4 early transcript was performed [22,23]. Infectivity of
mutant particles was established on equal multiplicity of infection
(MOI) based on the titers measured or by total L1 protein.
Infectivity of 10-day C428S, C175S, C185S, and C175,185S were
86%624, 3.5%61.2, 87%67, and 38%67, respectively, of wild-
type (Fig. 6) (Table 1). The drop in infectivity observed with
C175S and C175,185S does not appear to be due to the lack of an
interpentameric disulfide bond with C428 since C428S mutant
virus were nearly as infectious as wild-type (Fig. 6). We next tested
infectivity of 20-day C428S, C175S, C185S, and C175,185S virus
stocks. When compared to wild-type, the infectivity for 20-day
C428S, C175S, C185S, and C175,185S was 64%615, 46%68,
152%610, and 31%64, respectively (Table 1).
When we compared to 10-day wild-type virus, the infectivity
relative to L1 protein of 10-day C428S, C175S, C185S, and
C175,185S viruses was 41%628, 0.3%60.2, 148%660, and
Figure 5. Titers in 10 and 20-day wild-type and mutant viruses. Titers were measured using a SYBR-green based genome encapsidation
assay. (A) SYBR green-based DNA encapsidation assay relative quantification of 10-day wild-type (WT), C428S, C175S, C185S, and C175,185S viruses.
WT is set to 1.0. (B) SYBR green-based DNA encapsidation assay relative quantification of 20-day wild-type (WT), C428S, C175S, C185S, and C175,185S
viruses. WT is set to 1.0. (C) Side-by-side comparison of 10 (black bars) and 20-day (white bars) raw data from A and B. Relative y-axis values represent
copy number controls used in the standard curve. The results are means and standard errors for at least three independent experiments.
doi:10.1371/journal.pone.0022427.g005
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infectivityrelative to L1 protein of 20-day C428S, C175S,
C185S, and C175,185S viruses was 5%63, 0.1%60.1, 20%63,
and 10%69, respectively.
Capsid stabilities of wild-type and mutant virions
In Fig. 5A–C, genome encapsidation of viral genomes was
dramatically reduced in 10-day C175S viruses in addition to 20-
day C428S, C175S, C185S, and C175,185S viruses as compared
to wild-type. Rather than resulting from structural defects in
capsid assembly, reduction in endonuclease resistant genomes
might be due to a reduced ability of mutant viral genomes to
synthesize L1. Western blot analyses of wild-type and mutant virus
infected tissue showed that L1 expression of the mutant viruses was
similar to or greated than that of wild-type (Fig. 3B and Fig. 4C).
Considering the previously ascribed structural roles for C428,
C175, and C185 and that no decrease in L1 expression was
observed in tissues, we hypothesized that the reductions in
endonucease-resistant genomes observed in Fig. 5A–C was due
to structural defects in the mutant capsids.
We have previously demonstrated that highly infectious wild-
type virus migrates into Optiprep fractions #7 and #8 [22,23].
Therefore, to further examine the stability of these mutants, 20-
day viruses were Optiprep-fractionated and Western blot analyses
of L1 were performed on mature virus-containing, fractions #7
and #8 (Fig. 7A–B). It was observed that more L1 protein was
found in fractions #7 and #8 of wild-type compared to mutant
preparations (Fig. 7A–B). This decrease in L1 protein in mutant
fractions occurred while total L1 protein concentration in 20-day
viruses appeared equal or higher in mutant viruses compared to
wild-type virus (Fig. 4C). We hypothesized that, if mutant capsids
were more unstable than wild-type capsids, the majority of mutant
L1 protein would migrate to the top fractions of the Optiprep
gradient due to the destruction of capsids because of the high
forces of ultracentrifugation. Previously published data in our
laboratory suggested that such capsid destruction is prevalent in
immature, 10-day wild-type HPV16 virions and is mostly absent in
the more stable HPV16 20-day wild-type virions [23].
The instability of mutant capsids was compared to wild-type
capsids by assessing the relative stability of virus within the
Optiprep gradient (Fig. 8). The relative stability of virus was
measured by the ratio of unstably encapsidated viral genomes (sum
of fractions #1 through #4) over stably encapsidated viral
genomes (sum of fractions #6 through #9) [23]. We have shown
previously that 10-day wild-type HPV16 virions have a stability
ratio of 26.0, while their 20-day counterparts have a stability ratio
of 1.0, suggesting that HPV16 virions are stabilized over time [23].
While 20-day wild-type virions had a relative stability of 1.0, 20-
day C428S, C175, C185S, and C175,185S virions had relative
stabilities of 7.3, 13.8, 16.1, and 11.4, respectively, suggesting that
these mutations rendered capsids less stable than 20-day wild-type
virions (Fig. 8).
To determine if Optiprep-fractionated mutant virions retained
full infectivity, we performed the RT-qPCR-based infectivity assay
on each Optiprep fraction (Fig. 7D–E). Using equal titers (Fig. 7D)
or normalizing using total protein concentration (Fig. 7E, it was
apparent that, in contrast to the infectivity of mutant virions
directly from 20-day viral preparations (Fig. 6D), the infectivity of
Optiprep-fractionated mutant virions was dramatically less than
wild-type virions. This result indicated that mutant virions that did
migrate into into infectious fractions did not retain the same level
of infectivity as their counterparts tested directly from unfraction-
ated viral preparations. Gradient-purified mutant virions might
not be as stable as wild-type virions and the observed reduction in
total L1 protein concentrations within mutant Optiprep gractions
might by due to the instability of their capsids. Optiprep fractions
outside of fractions #7 and #8 were scanned but yielded no
higher infectivity peaks. This suggested that the result was not due
Table 1. Titers and infectivity of cys mutants.
Titers (% change compared to
wild-type ± SD)
Infectivity (% change compared
to wild-type ± SD)
Infectivity Relative To L1 Protein (%
change compared to wild-type ± SD)
Mutants 10-day 20-day 10-day 20-day 10-day 20-day
C428S 54%614 8%648 6 % 624 64%615 41%628 5%63
C175S 20%615 1%60.05 3.5%61.2 46%68 0.3%60.2 0.1%60.1
C185S 110%630 13%648 7 % 67 152%610 148%660 20%63
C175,185S 145%651 14%663 8 % 673 1 % 644 9 % 626 10%69
doi:10.1371/journal.pone.0022427.t001
Figure 6. Infectivity of 10 and 20-day wild-type and mutant virions. (A) Infectivity was assayed using equal titers of 10-day wild-type (WT),
C428S, C175S, C185S, C175,185S viruses. Relative endonuclease-resistant genome data in Fig. 5A was used to normalize relative infectivity data in A.
WT is set to 1.0. (B) Infectivity of 20-day wild-type (WT), C428S, C175S, C185S, C175,185S viruses. WT is set to 1.0.The results are means and standard
errors for at least three independent experiments.
doi:10.1371/journal.pone.0022427.g006
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capsids were falling apart, or that these residues were important
for an unknown entry step.
Interestingly, when we compared the total amount of
endonuclease-resistant genomes within each Optiprep fraction
and normalized for total L1 protein concentration, we observed
a dramatic defect in DNA encapsidation efficiency of C428S
and C175S virions (Fig. 5A–B and Fig. 7C). In contrast to data
in Fig. 5B, C185S virions contained equal or more viral
genomes per total L1 protein concentration compared to wild-
type. The discrepancy between the DNA encapsidation
efficiencies versus total L1 protein concentration might be due
to extensive capsid instability of C185S capsids that do not
contain a viral genome. In this scenario, only C185S capsids
that have properly encapsidated and protected their genomes
from endonucleases migrate into the highly infectious fractions.
Another possibility would be that C185S virions are much
smaller than wild-type virions, but still contain a full-length
genome. These possibilities are supported by previous data
utilizing HPV16 VLPs, which depict C185S capsids as smaller
than wild-type capsids, and C175S capsids as much larger than
wild-type capsids [16].
Oxidative glutathione (GSSG)-induced treatment of
wild-type and mutant virions
Previous studies have shown that treatment of HPV PsV or
HPV-infected organotypic raft cultures with 5 mM GSSG
enhances capsid maturation. However, work with PsV suggests
that GSSG treatment also results in an increase in misfolded
capsids since they are more susceptible to partial tryptic proteolysis
than untreated capsids [6,23]. Our previous research has shown
that treatment of HPV16-infected organotypic raft cultures with
5 mM GSSG starting on day 8 and ending on day 10, followed by
harvesting of the tissue, leads to enhanced infectivity [23]. Similar
results have also been observed through the addition of low
concentrations of the mildly oxidizing agent DMSO (data not
shown). Since previous research utilizing HPV PsV showed a role
for C428S and C175S in capsid maturation, we tested whether or
not C428S, C175S, C185S, or C175,185S mutant viruses would
respond to GSSG-treatment as compared to wild-type virus
Figure 7. Analysis of infectious Optiprep fractions. (A) Western blot analysis of L1 in highly infectious Optiprep fractions #7 and #8 from
Optiprep-fractionated 20-day wild-type (WT), C428S, C175S, C185S, and C175,185S viruses. The two rows are replicates with the top being
overexposed. Higher and lower molecular weight species of L1 are indicated. (B) Densitometric analysis of the faster migrating L1 species (i.e. 55 kD)
in three independent Western blots as shown in A. WT fraction #7 was set to 1.0. (C) Titers per fraction, normalized to the relative amount of L1
protein within fractions. WT fraction #7 was set to 1.0. (D) Infectivity of 20-day wild-type (WT), C428S, C175S, C185S, C175,185S virions within
fractions #7 and #8. WT is set to 1.0. (E) Infectivity of 20-day wild-type (WT), C428S, C175S, C185S, C175,185S virions within fractions #7 and #8.
Relative L1 protein content per fraction were used to normalize relative infectivity data within fractions. WT is set to 1.0.The results are means and
standard errors for at least three independent experiments. The arrow points to the L1 band with the same motility as seen with L1 from PsV [23]. The
asterisk marks the slow mobility L1 band seen only in native HPV16 virion [23].
doi:10.1371/journal.pone.0022427.g007
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organotypic tissues resulted in an approximately 3.5-fold increase
in infectivity and a 2-fold increase in total endonuclease-resistant
genomes (Fig. 9A–B). As previously reported, this phenomenon
only occurred when treated with GSSG starting on day 8 and
ending on day 10 (Fig. 9A–B) [23]. It did not occur when treated
with GSSG starting on day 15 and ending on day 20 (Fig. 9A–B).
None of the mutant viruses C428S, C175S, C185S, or C175,185S
responded to GSSG-treatment when starting on day 8 and ending
on day 10 (Fig. 9A–B). In fact, similar to data in Fig. 5C which
showed a decrease in titer of 20-day mutant viruses compared to
10-day mutant viruses, titers and infectivity appeared to decrease
in most instances upon treatment with 5 mM GSSG (Fig. 9A–B).
These results suggest that under the influence of the natural tissue-
spanning redox gradient between days 10 and 20, or via early
treatment of virions with 5 mM GSSG, mutant virions appear to
be destabilized either by a lack of stabilizing disulfide bonds or
through incorrectly formed intra- and/or interpentameric disulfide
bonds between the mutant L1 proteins.
Discussion
In this study, we sought to determine individual temporal roles
for the highly conserved HPV16 L1 cysteine residues: C428,
C175, and C185 in capsid assembly within the context of
stratifying and differentiating human epithelial tissue, HPV’s
natural host environment. Previous studies have depicted that
C428S and C427S mutations in HPV16 and HPV33 VLPs,
respectively, lead to the complete loss of capsid integrity, being
disrupted into their respective capsomeres [16,18,20]. These
studies have been extended to HPV16 PsV whereby C428S
mutations also lead to the failure of capsids to form mature
particles, suggesting a role for this residue in initial assembly and
perhaps maturation [6]. A role for C428 in the formation of a
critical interpentameric disulfide bond is supported by biochemical
and cryo-electron microscopy data of non-reduced L1 dimers from
HPV18 VLPs whereby an interpentameric disulfide bond between
C175 and C429 is formed [14,21]. A recent high-resolution cryo-
electron microscopy image of native BPV also confirms the
presence of a C171–C426 interpentameric disulfide bond [21].
However, the C175S substitution in both HPV16 VLPs and PsV
does not lead to reciprocal complete disruption of capsids to
capsomeres as is seen with the C428S mutant in VLPs and PsV.
Instead, long tubular structures are formed as seen via EM and
aberrant dimer formation is observed via Western blot analysis
[6,16]. These results suggest that, in HPV16, interpentameric
contacts are possible without C175.
Thought to reside on an external loop neighboring C175, it has
been suggested by others that C185 might form similar
interpentameric contacts with C428 with only minor structural
rearrangements of this loop [6,13,16,21]. While the most recent
high-resolution cryo-electron microscopy image reconstruction of
native BPV virions only depicted a disulfide bond homologous to
HPV16’s C175–C428 disulfide bond and not a C185–C428
disulfide bond, this might be due to the low abundance or
asymmetry of C185–C428 disulfides which are averaged out of the
reconstruction [21]. Our data suggests that C175–C428 may
occur prior to C185 and that when C175 is missing the C185–
C428 bond can occur. It is possible that C185–C428 occurs early
and may assist in preparing for a switch to C175–C428.
Additionally, the double mutation, C175S/C185S prevents the
deleterious C428-C185 bond to form/remain in the oxidative
environment of 20 day tissues in the absence of C175.
Our data suggests that all three conserved cysteine residues,
C428, C175, and C185 are critical for proper assembly and
maturation of native HPV16 virions. While no individual
substitution led to the complete disruption of particles as was
previously seen with C428S mutations in HPV16 VLPs and PsV,
each substitution undermined particle formation efficiency and
stability. These virions were more susceptible to intrusion of
endonucleases into the capsid lumen, and less able to withstand the
forces of ultracentrifugation [6,16,18]. In addition, all three
mutations led to a deficiency in capsid maturation when exposed
either to the natural, tissue-spanning redox gradient or through
artificial treatment with GSSG. Further, studies of HPV16 VLP
assembly showed rapid assembly under acidic conditions (pH 5.2)
indicative of a kinetic trap due to overinitiated assembly [33]. Only
at pH 6.2, 7.2, and 8.2 did particles avoid aggregation and
particles produced at pH 7.2 disassembled slower than the rest.
We hypothesize that alterations in the chemical environment of
tissue can affect the quality and quantity of the resulting
papillomavirus particle [33].
Contrary to work with VLPs and PsV, in the context of
organotypic culture-derived native virions, the C428S mutation
led to approximately 50% of wild-type titers within 10-day viral
preparations suggesting that hydrophobic interactions and/or
cellular factors are involved in reinforcing the integrity of C428S
virions [6,16,18,34,35,36]. We hypothsize that within the
suprabasal compartment of 10-day tissues, assembly of wild-type
virions is promoted by extensive hydrophobic interactions. In this
temporospatial environment, these interactions most likely take
place between neighboring L1 pentamers, and between L1
pentamers and monomeric L2, assisted by cellular chaperones
[7,13,14,17,21,34,35,36,37,38]. Knowledge of the structure,
location, and number of L2 molecules in the capsid is at best
sparse. While effects on L2 are possible reasons for the phenotypes
observed too little is known about L2 in the capsid to draw any
conclusions.
In Fig. 5A–C, it is apparent that the C175S mutation severely
limits the number of endonuclease-resistant genomes that are
present within 10-day virus, while C185S and C175,185
mutations do not appear to be limiting. We hypothesize that it
is possible for a capsid to contain a mixture of both C175–C428
Figure 8. Relative stabilities of 20-day wild-type versus mutant
virions. 20-day wild-type (WT), C428S, C175S, C185S, and C175,185S
viruses were Optiprep-fractionated. Fractions were assayed by a SYBR
green-based DNA encapsidation assay to detect total endonuclease-
resistant genomes per fraction. As a measure of capsid stability, the sum
of genomes in the uppermost gradient fractions (fractions #1 through
#4) was described as ‘‘unstable’’ (US), which were genomes either not
associated or disassociated from an intact capsid during ultracentrifu-
gation. The sum of genomes flanking highly infectious fractions
(fractions #6 through #9) was described as ‘‘stable’’ (S) since they
were associated with intact capsids. Relative capsid stability is described
by the ratio US/S, whereby higher values indicate more unstable virions
[23].
doi:10.1371/journal.pone.0022427.g008
Native HPV16 L1 Cysteines in Virion Morphogenesis
PLoS ONE | www.plosone.org 7 July 2011 | Volume 6 | Issue 7 | e22427and C185–C428 disulfide bonds with C185–C428 disulfide bonds
being in the minority. In this scenario, the substitution of C175
for serine inhibits the formation of C175–C428 disulfide bonds,
and allows for the formation of a larger percentage of C185–
C428 interpentameric disulfide bonds that are less efficient in
stabilizing the particle. Another possibility is that C175S
mutations might alter an unknown early role for C175 in
assembly. However, the formation of improper C185–C428
disulfides is supported by previous studies utilizing C175S mutant
HPV16 VLPs and PsV which lead to the production of abnormal
tubular structures via EM and the production of aberrant L1
dimers, respectively [6,16]. But nonreducing Western blot
analysis of 10-day C175S virus does not depict L1 dimer
formation, suggesting that if C185-C428 disulfides do take place,
they are in the minority (Fig. 4A).
Analysis of 20-day viruses reveals the temporal importance of
C175, C428 and C185. Titers remain low in 20-day C175S viral
preparations as they had in 10-day viral preparations. Titers for
C428S and C185S mutations were significantly down within20-day
viral preparations (Fig. 5B). This observation suggests that either, (i)
C185and C428 form a disulfide during maturation within tissue, (ii)
that C185 effects a more extensive C175–C428 disulfide bonds, (iii)
that C185S mutations alter the environment within the E–F loop
>which makes it difficult for C175–C428 disulfides to form, or (iv)
the potential structural effect of the serine residues could induce a
shift in the loops. Due to previous structural analyses of capsids
which have depicted a C175–C428 endpoint disulfide bond, we
hypothesize that a transient C185–C428 disulfide bond occurs
which primes final C175–C428 disulfide bonds [14,21]. This
hypothesis is in line with previously reported studies [6,16].
Figure 9. GSSG treatment alters viral titers and infectivity of tissues. (A) Relative RT-qPCR infectivity assay of wild-type (WT), C428S, C175S,
C185S, and C175,185S 10 and 20-day viruses made from untreated (white) versus 5 mM GSSG-treated (black) organotypic cultures treated during
days 8 through 10 or during days 15 through 20. Untreated 10-day WT was set to 1.0. (B) SYBR green-based DNA encapsidation assay of wild-type
(WT), C428S, C175S, C185S, C175,185S 10 and 20-day viruses made from untreated (white) versus 5 mM GSSG-treated (black) organotypic cultures
treated during days 8 through 10 or during days 15 through 20. Untreated 10-day WT was set to 1.0. Results are means and standard errors for three
independent experiments.
doi:10.1371/journal.pone.0022427.g009
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bonding between C428, C175, and C185, is our finding that
C428S, C175S, C185S, and C175,185S 20-day viral preparations
have a significant decrease in titers compared to their 10-day
counterparts. This suggests that each of these residues is important
in the efficient accumulation of mature capsids (Fig. 5C). This
result is supported by GSSG treatment of wild-type and mutant-
infected tissues whereby virions within the mutant-infected tissues
failed to respond to the oxidizing agent (Fig. 9). When normalized
by titer or L1 protein levels the particles that do form appear to be
less infectious. This could be due to the overall structure of the
formed particles is not correct, thus an indirect effect on
attachment, entry, or trafficking.
Materials and Methods
DNA reagents
pBSHPV16(114/B) DNA, a generous gift from M. Du ¨rst
(Kirnbauer et al., 1993) was utilized as the template for site-
directed mutagenesis using Strategene’s Quikchange II XL Site-
Directed Mutagenesis Kit. Following transformation and selection
of the mutant amplimers into XL10 Ultracompetent E. coli cells
(Stratagene, La Jolla, Calif.), we controlled for polymerase fidelity
and/or random mutations that may arise during PCR amplifica-
tion by extracting plasmid DNA from many isolated bacterial
clones and sequencing the L1 ORF of each clone to verify the
correct incorporation of nucleotide substitutions and the absence
of spurious mutations elsewhere in the L1 ORF. Multiple mutant
viral genomic clones containing correctly mutagenized sequences
were isolated per each mutation and utilized in subsequent
experimentation. To create a full-length, HPV16(114/B) genome
with a Cys175Ser substitution, the two complimentary oligonu-
cleotides: forward 59CTGGGGCAAAGGATCCCCATCTAC-
CAATGTTGCAGTAAATC39 and reverse 59GATTTACTG-
CAACATTGGTAGATGGGGATCCTTTGCCCCAG39, were
used with the change of G to C at nucleotide 6161. To create a
full-length, HPV16(114/B) genome with a Cys185Ser substitution,
the two complimentary oligonucleotides: forward 59GCAG-
TAAATCCAGGTGATTCTCCACCATTAGAG39 and reverse
59CTCTAATGGTGGAGATCACCTGGATTTACTGC39, were
used with the change of G to C at nucleotide 6191. To create a
full-length, HPV16(114/B) genome with a Cys428Ser substitution,
the two complimentary oligonucleotides: forward 59GTAACC-
CAGGCAATTGCTTCTCAAAAACATACACCTCC39 and re-
verse 59GGAGGTGTATGTTTTTGAGAAGCAATTGCCTG-
GGTTAC39, were used with the change of G to C at nucleotide
6917. To create a full-length, HPV16(114/B) genome with
Cys175,185Ser substitutions, the two complimentary oligonucle-
otides: forward 59GCAGTAAATCCAGGTGATTCTCCAC-
CATTAGAG39 and reverse 59CTCTAATGGTGGAGATCA-
CCTGGATTTACTGC39, were used with the change of G to C
at nucleotides 6161 and 6191, respectively. The Cys175,185Ser
amplimers were made utilizing the Cys175Ser template. In all
instances, the most prevalent serine codon in the HPV16(114/B)
L1 ORF, TCT, was utilized.
Differentiation-dependent native virion production
Immortalized HFK lines which stably maintained episomal
HPV16 DNA were grown in monolayer culture using E medium
in the presence of mitomycin C-treated J2 3T3 feeder cells [39].
Raft tissues were grown as previously described [27,39,40]. For
oxidized glutathione (GSSG) (Sigma) treatment, E-media was
supplemented with the appropriate concentration and fed to
organotypic cultures either beginning on day eight followed by
tissue harvest on day ten (8 to 10-day), or beginning on day fifteen
followed by tissue harvest on day twenty (15 to 20-day).
Keratinocyte cultures, and electroporation
Primary human foreskin keratinocytes (HFKs) were isolated and
grown from newborn circumcision as described previously
[27]. For electroporations, 30 mg of wild-type or mutagenized
pBSHPV16(114/B) DNA was digested with BamHI, linearizing the
viral DNA at nucleotide 6151 in L1 and separating it from the
vector sequence. HFKs were electroporated with the prepared
DNA as described previously [27,39]. Multiple cell lines were
obtained for each wild-type and mutant construct.
Southern blot hybridization
Total cellular DNA was isolated as previously described [39].
Briefly, 5 mg of total cellular DNA was digested with BamHI, which
linearizes the HPV16 genome. Samples were separated by 0.8%
agarose gel electrophoresis and transferred onto a GeneScreen
Plus membrane (New England Nuclear Research Products) as
previously described [41]. Hybridization of the membrane utilized
an HPV16-specific, whole genomic probe as previously described.
[39].
Histology and immunohistochemical staining
Tissues were fixed in 10% neutral buffered formalin, and
embedded in paraffin. Four-micrometer sections were cut and
stained with hematoxylin and eosin as previously described [39].
HPV isolation
For Optiprep fractionation, RT-PCR, RT-qPCR, and qPCR-
based DNA encapsidation assays, 3-raft tissues viral preparation or
VLP and PsV lysates were prepared by dounce homogenization in
500 ml phosphate buffer (0.05 M Na-phosphate [pH 8.0], 2 mM
MgCl2). Homogenizers were rinsed with 250 ml phosphate buffer.
1.5 ml (375 units) Benzonase (Sigma) was added to 750 ml of CVPs
and incubated at 37uC for 1 hour. Samples were brought to 1 M
NaCl by adding 130 ml ice cold 5 M NaCL. Then, samples were
vortexed and centrifuged at 4uC for 10 minutes at 10,500 rpm in a
microcentrifuge. Supernatants were stored at 220uC.
Optiprep purification of virions
Optiprep purification was performed as described previously
[12,42]. Briefly, 27%, 33%, 39% Optiprep gradients were
produced by underlayering. Gradients were allowed to diffuse
for 1 to 2 h at room temperature. Then, 600 ml of clarified
benzonase-treated virus preps were layered on top of the gradient.
Tubes were then centrifuged in a SW55 rotor (Beckman) at
234,0006 g for 3.5 h at 16uC. After centrifugation, 11–500 ml
fractions were collected from the top of each tube.
Quantitative RT-qPCR infectivity assays
HaCaT cells were grown to confluence in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal bovine serum,
2 mM glutamine, 1 mM pyruvate, 100 units/ml penicillin, and
100 mg/ml streptomycin and seeded 50,000 cells/well in 24-well
plates. 50 ml of HPV16 viral stock was diluted with cell culture
medium to a total volume of 0.5 ml. Medium was aspirated from
HaCaT cells and 0.5 ml of diluted virus was added per well. One
well on each plate received 0.5 ml of medium without virus as a
negative control. The cells were incubated with the virus for 48 h
at 37uC. mRNA was harvested with the SurePrep TrueTotal
RNA Purification Kit (Fisher Scientific). DNA contamination of
columns was insignificant in that the optional on-column DNase-I
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Amplification of both the viral target and endogenous cellular
control target was performed using a duplex format in 0.2 ml, 96-
well PCR plates (BIO-RAD) with a total reaction volume of 25 ml.
All reactions containing RNAs from virus-infected cells were
performed in duplicate or triplicate. Reverse transcription and
quantitative PCR were performed in the same closed tube with
approximately 250 ng of total RNA per reaction using the
Quantitect Probe RT-PCR Kit (Qiagen). HPV16 E1‘E4 primers
used were the splice-site straddling, forward 59GCTGATCCTG-
CAAGCAACGAAGTATC39 (nt 868–3372) and reverse 59GG-
ATTGGAGCACTGTCCACTGAG 39 (nt 3535–3557) at final
concentrations of 4 mM. A fluorogenic, dual-labeled, HPV16
E1‘E4 probe of 59 6-FAMCACCGGAAACCCCTGCCACAC-
CACTAAGBHQ-1 39 (nt 3493–3520) was utilized at a final
concentration of 0.2 mM to detect E1‘E4 cDNA. Primers and
probe were developed using Gene Link Software: OligoAnalyzer
1.2, and OligoExplorer 1.2. TATA-binding protein (TBP) amp-
licons were created using primers 59 CACGGCACTGATTTT-
CAGTTCT 39 (nt 627–648) and 59 TTCTTGCTGCCAGT-
CTGGACT 39 (nt 706-686) at final concentrations of 0.125 mM.
TBP amplicons were detected by the fluorogenic TaqManTM
probe 59HEX TGTGCACAGGAGCCAAGAGTGAAGA BHQ-
139 used at 0.2 mM. TBP primer sequences were obtained from
those previously described [43]. All primers were synthesized by
Integrated DNA Technologies (Coralville, IA). All QRT-PCR
reactions were performed using the iQ5 (BIO-RAD). Cycling
conditions were 50uC for 30 min (reverse transcription) and 95uC
for 15 min, followed by 42 cycles of 94uC for 15 s and 54.5uC for
1 min. Amplification efficiencies of each primer set was 93% for
E1‘E4 and 97% for TBP. Relative quantities of viral target cDNA
were determined using REST software.
qPCR-based DNA encapsidation assay
To detect endonuclease-resistant genomes in viral preparations
or Optiprep fractions, only benzonase-treated samples were used
so that all non-encapsidated genomes were digested. To release all
encapsidated viral genomes, 10 ml sonicated virus preparation or
20 ml Optiprep fraction was added to 2 ml Proteinase K, 10 ml
10% SDS, 2 ml pCMV-GFP (140 ng/ml) carrier DNA, and
brought up to 200 ml with Hirt buffer. Tubes were rotated at
37uC for 2 hours. Immediately, an equal amount of phenol-
chloroform-isoamyl alcohol (25:24:1) was added and the mixture
was extracted for the aqueous phase. An equal amount of
chloroform was added and again extracted for the aqueous phase.
DNA was EtOH precipitated overnight at 220uC. After
centrifugation, the DNA pellet was washed with 70% EtOH and
resuspended in 20 ml TE overnight. To detect viral genomes or
cellular DNA, a Qiagen Quantitect SYBR Green PCR kit was
utilized. Amplification of the viral target was performed in 0.2 ml,
96-well PCR plates (BIO-RAD) with a total reaction volume of
25 ml. l ml of each endonuclease-resistant viral genome prep was
analyzed in triplicate for each independent experiment. Amplifi-
cation of HPV16 genomes was performed using 0.3 mM
59CCATATAGACTATTGGAAACACATGCGCC39 as the for-
ward primer (nt 2839–2868) and 0.3 mM5 9CGTTAGTTG-
CAGTTCAATTGCTTGTAATGC39 as the reverse primer (nt
2960–2989). Amplification of human repetitive Alu DNA was
performed using 0.3 mM5 9GTCAGGAGATCGAGACCATC-
CC39 as the forward primer and 0.3 mM5 9TCCTGCCTC-
AGCCTCCCAAG39 as the reverse primer [44]. Oligonucleotides
were synthesized by Integrated DNA Technologies (Coralville,
IA). A standard curve was generated by amplifying serially-diluted
pBSHPV16 copy number controls. Acceptable R
2 values for
standard curves were at or above 0.99. A Bio-Rad iQ5 Multicolor
Real-Time qPCR machine and software were utilized for PCR
amplifications and subsequent data analysis. The PCR thermo-
cycling profile was as follows: 15 min. hot-start at 95uC, followed
by 40 cycles at 15 sec. at 94uC, 30 sec. at 52uC, and 30 sec. at
72uC. Data analysis commenced during the extension phase.
Immunoblot analysis
40 ml aliquots from Optiprep fractions were boiled for
10 minutes in 6% 2-ME loading buffer and loaded on 8%
polyacrylamide gels. To detect HPV16 L1, anti-HPV16 L1
monoclonal antibody (Camvir-1; BD Pharmingen) was utilized
at a dilution of 1:4,000 per manufacturer’s recommendations. For
nonreducing gels, loading buffer without 2-ME was utilized.
Samples were boiled for 10 minutes at 70uC and loaded on 6%
polyacrylamide gels. L1 was detected using the anti-HPV16 L1
monoclonal antibody, H16.J4 [45].
Acknowledgments
We thank Lynn Budgeon for histological expertise, and the Meyers’ lab for
critical reading of this manuscript.
Author Contributions
Conceived and designed the experiments: MJC LC SA NDC CM.
Performed the experiments: MJC LC SA. Analyzed the data: MJC LC SA
NDC CM. Contributed reagents/materials/analysis tools: MJC LC SA
NDC CM. Wrote the paper: MJC LC CM.
References
1. Trus BL, Roden RB, Greenstone HL, Vrhel M, Schiller JT, et al. (1997)
Novel structural features of bovine papillomavirus capsid revealed by a
three-dimensional reconstruction to 9 A resolution. Nat Struct Biol 4:
413–420.
2. Baker TS, Drak J, Bina M (1989) The capsid of small papova viruses contains 72
pentameric capsomeres: direct evidence from cryo-electron-microscopy of
simian virus 40. Biophys J 55: 243–253.
3. Baker TS, Newcomb WW, Olson NH, Cowsert LM, Olson C, et al. (1991)
Structures of bovine and human papillomaviruses. Analysis by cryoelectron
microscopy and three-dimensional image reconstruction. Biophys J 60:
1445–1456.
4. Belnap DM, Olson NH, Cladel NM, Newcomb WW, Brown JC, et al. (1996)
Conserved features in papillomavirus and polyomavirus capsids. J Mol Biol 259:
249–263.
5. Conway MJ, Meyers C (2009) Replication and assembly of human papilloma-
viruses. J Dent Res 88: 307–317.
6. Buck CB, Thompson CD, Pang YY, Lowy DR, Schiller JT (2005) Maturation of
papillomavirus capsids. J Virol 79: 2839–2846.
7. Finnen RL, Erickson KD, Chen XS, Garcea RL (2003) Interactions between
papillomavirus L1 and L2 capsid proteins. J Virol 77: 4818–4826.
8. Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT (1992) Papillomavirus L1
major capsid protein self-assembles into virus-like particles that are highly
immunogenic. Proc Natl Acad Sci U S A 89: 12180–12184.
9. Kirnbauer R, Taub J, Greenstone H, Roden R, Durst M, et al. (1993) Efficient
self-assembly of human papillomavirus type 16 L1 and L1–L2 into virus-like
particles. J Virol 67: 6929–6936.
10. Buck CB, Cheng N, Thompson CD, Lowy DR, Steven AC, et al. (2008)
Arrangement of L2 Within the Papillomavirus Capsid. J Virol.
11. Culp TD, Cladel NM, Balogh KK, Budgeon LR, Mejia AF, et al. (2006)
Papillomavirus particles assembled in 293TT cells are infectious in vivo. J Virol
80: 11381–11384.
12. Buck CB, Pastrana DV, Lowy DR, Schiller JT (2004) Efficient intracellular
assembly of papillomaviral vectors. J Virol 78: 751–757.
13. Chen XS, Garcea RL, Goldberg I, Casini G, Harrison SC (2000) Structure of
small virus-like particles assembled from the L1 protein of human papillomavirus
16. Mol Cell 5: 557–567.
14. Modis Y, Trus BL, Harrison SC (2002) Atomic model of the papillomavirus
capsid. Embo J 21: 4754–4762.
15. Ishii Y, Kondo K, Matsumoto T, Tanaka K, Shinkai-Ouchi F, et al. (2007)
Thiol-reactive reagents inhibits intracellular trafficking of human papillomavirus
Native HPV16 L1 Cysteines in Virion Morphogenesis
PLoS ONE | www.plosone.org 10 July 2011 | Volume 6 | Issue 7 | e22427type 16 pseudovirions by binding to cysteine residues of major capsid protein L1.
Virol J 4: 110.
16. Ishii Y, Tanaka K, Kanda T (2003) Mutational analysis of human
papillomavirus type 16 major capsid protein L1: the cysteines affecting the
intermolecular bonding and structure of L1-capsids. Virology 308: 128–136.
17. Ishii Y, Ozaki S, Tanaka K, Kanda T (2005) Human papillomavirus 16 minor
capsid protein L2 helps capsomeres assemble independently of intercapsomeric
disulfide bonding. Virus Genes 31: 321–328.
18. Sapp M, Fligge C, Petzak I, Harris JR, Streeck RE (1998) Papillomavirus
assembly requires trimerization of the major capsid protein by disulfides between
two highly conserved cysteines. J Virol 72: 6186–6189.
19. Fligge C, Schafer F, Selinka HC, Sapp C, Sapp M (2001) DNA-induced
structural changes in the papillomavirus capsid. J Virol 75: 7727–7731.
20. Li M, Beard P, Estes PA, Lyon MK, Garcea RL (1998) Intercapsomeric disulfide
bonds in papillomavirus assembly and disassembly. J Virol 72: 2160–2167.
21. Wolf M, Garcea RL, Grigorieff N, Harrison SC Subunit interactions in bovine
papillomavirus. Proc Natl Acad Sci U S A 107: 6298–6303.
22. Conway MJ, Alam S, Christensen ND, Meyers C (2009) Overlapping and
independent structural roles for human papillomavirus type 16 L2 conserved
cysteines. Virology 393: 295–303.
23. Conway MJ, Alam S, Ryndock EJ, Cruz L, Christensen ND, et al. (2009) Tissue-
spanning redox gradient-dependent assembly of native human papillomavirus
type 16 virions. J Virol 83: 10515–10526.
24. Conway MJ, Cruz L, Alam S, Christensen ND, Meyers C (2011) Cross-
neutralization potential of native human papillomavirus N-terminal L2 epitopes.
PLoS One In Press.
25. McLaughlin-Drubin ME, Christensen ND, Meyers C (2004) Propagation,
infection, and neutralization of authentic HPV16 virus. Virology 322: 213–219.
26. Meyers C, Mayer TJ, Ozbun MA (1997) Synthesis of infectious human
papillomavirus type 18 in differentiating epithelium transfected with viral DNA.
J Virol 71: 7381–7386.
27. McLaughlin-Drubin ME, Wilson S, Mullikin B, Suzich J, Meyers C (2003)
Human papillomavirus type 45 propagation, infection, and neutralization.
Virology 312: 1–7.
28. Foreman KE, Friborg J, Jr., Kong WP, Woffendin C, Polverini PJ, et al. (1997)
Propagation of a human herpesvirus from AIDS-associated Kaposi’s sarcoma.
N Engl J Med 336: 163–171.
29. Kedes DH, Ganem D (1997) Sensitivity of Kaposi’s sarcoma-associated
herpesvirus replication to antiviral drugs. Implications for potential therapy.
J Clin Invest 99: 2082–2086.
30. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, et al. (1996) Lytic
growth of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) in
culture. Nat Med 2: 342–346.
31. Flore O, Rafii S, Ely S, O’Leary JJ, Hyjek EM, et al. (1998) Transformation of
primary human endothelial cells by Kaposi’s sarcoma-associated herpesvirus.
Nature 394: 588–592.
32. Friborg J, Jr., Kong WP, Flowers CC, Flowers SL, Sun Y, et al. (1998) Distinct
biology of Kaposi’s sarcoma-associated herpesvirus from primary lesions and
body cavity lymphomas. J Virol 72: 10073–10082.
33. Mukherjee S, Thorsteinsson MV, Johnston LB, DePhillips PA, Zlotnick A (2008)
A quantitative description of in vitro assembly of human papillomavirus 16 virus-
like particles. J Mol Biol 381: 229–237.
34. Song H, Moseley PL, Lowe SL, Ozbun MA (2010) Inducible heat shock protein
70 enhances HPV31 viral genome replication and virion production during the
differentiation-dependent life cycle in human keratinocytes. Virus Res 147:
113–122.
35. Chromy LR, Pipas JM, Garcea RL (2003) Chaperone-mediated in vitro
assembly of Polyomavirus capsids. Proc Natl Acad Sci U S A 100: 10477–10482.
36. Chromy LR, Oltman A, Estes PA, Garcea RL (2006) Chaperone-mediated in
vitro disassembly of polyoma- and papillomaviruses. J Virol 80: 5086–5091.
37. Bird G, O’Donnell M, Moroianu J, Garcea RL (2008) A Possible Role for
Cellular Karyopherins in Regulating Polyomavirus and Papillomavirus Capsid
Assembly. J Virol.
38. Day PM, Baker CC, Lowy DR, Schiller JT (2004) Establishment of
papillomavirus infection is enhanced by promyelocytic leukemia protein
(PML) expression. Proc Natl Acad Sci U S A 101: 14252–14257.
39. Meyers C, Frattini MG, Hudson JB, Laimins LA (1992) Biosynthesis of human
papillomavirus from a continuous cell line upon epithelial differentiation.
Science 257: 971–973.
40. McLaughlin-Drubin ME, Meyers C (2005) Propagation of infectious, high-risk
HPV in organotypic ‘‘aft’’culture. Methods Mol Med 119: 171–186.
41. Smith JL, Campos SK, Ozbun MA (2007) Human papillomavirus type 31 uses a
caveolin 1- and dynamin 2-mediated entry pathway for infection of human
keratinocytes. J Virol 81: 9922–9931.
42. Gambhira R, Karanam B, Jagu S, Roberts JN, Buck CB, et al. (2007) A
protective and broadly cross-neutralizing epitope of human papillomavirus L2.
J Virol 81: 13927–13931.
43. Culp TD, Christensen ND (2003) Quantitative RT-PCR assay for HPV
infection in cultured cells. J Virol Methods 111: 135–144.
44. Nicklas JA, Buel E (2003) Development of an Alu-based, real-time PCR method
for quantitation of human DNA in forensic samples. J Forensic Sci 48: 936–944.
45. Christensen ND, Cladel NM, Reed CA, Budgeon LR, Embers ME, et al. (2001)
Hybrid papillomavirus L1 molecules assemble into virus-like particles that
reconstitute conformational epitopes and induce neutralizing antibodies to
distinct HPV types. Virology 291: 324–334.
Native HPV16 L1 Cysteines in Virion Morphogenesis
PLoS ONE | www.plosone.org 11 July 2011 | Volume 6 | Issue 7 | e22427